The current study provided evidences that BXYS played a role in improving heart function and delaying the progress of renal fibrosis, meanwhile CTGF-LRP pathway showed a positive change after treated with BXYS, which might be a new target and therapeutic strategy for myocardial infarction caused type 2 CRS and is worthy of further exploration. This evidence concerns the gene CCN2 and renal fibrosis.